Axil Capital | Mitsui Link-Fund

corporate vc$40MCo-investsLeads rounds

◆ Fund Size

$40M

◆ Location

Japan

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Investment Thesis

Life sciences and healthcare CVC focused on biopharmaceuticals, medical devices, regenerative medicine, healthcare and healthtech, with the newly announced Mitsui Link-Fund targeting seed through later-stage startups in drug discovery, medical devices, regenerative medicine, and healthcare/healthtech.

◆ About Axil Capital

A ¥7 billion corporate venture capital fund investing in drug discovery, medical devices, regenerative medicine, and health tech startups from seed to later stages across Japan and abroad.

◆ Sectors

Drug DiscoveryMedtechHealthtech InfrastructureRegenerative Medicine

◆ Stages

seedseries-aseries-bgrowth

◆ Geography Focus

Japan

◆ Team

Name	Title	Role	Links
Frederick Schen	Representative	—

◆ Notable Investments

LinkMedTaiAx Life Science Fund L.P.Fore BiotherapeuticsPulmotectCranebioTechsoMedLinqMed

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Mitsui Link-Fund invest in?

Mitsui Link-Fund invests in Drug Discovery, Medtech, Healthtech Infrastructure and Regenerative Medicine at the seed, series-a, series-b and growth stages.

Which geographies does Mitsui Link-Fund focus on?

Mitsui Link-Fund focuses on Japan, and is headquartered in Japan.